[Retracted] Knockdown of miR‐372‐3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF‐1α Signaling Pathway and Suppressing Oxidative Stress

Abstract

MiR-372-3p KD inhibits the development of DCM <i>via</i> activating the PI3K/AKT/mTOR/HIF-1<i>α</i> signaling pathway or suppressing oxidative stress. This offers an applicable biomarker for DCM treatment.